ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+6.42%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$4.21B
AUM Growth
+$290M
(+7.4%)
Cap. Flow
+$44.3M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
19.84%
Holding
1,462
New
252
Increased
614
Reduced
435
Closed
141
Top Buys
| 1 |
NVIDIA
NVDA
|
+$37.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$30.2M |
| 3 |
Verizon
VZ
|
+$29.5M |
| 4 |
Microsoft
MSFT
|
+$21.8M |
| 5 |
Gilead Sciences
GILD
|
+$19.8M |
Top Sells
| 1 |
Tesla
TSLA
|
+$19.4M |
| 2 |
AbbVie
ABBV
|
+$19.1M |
| 3 |
Johnson & Johnson
JNJ
|
+$17.8M |
| 4 |
ServiceNow
NOW
|
+$15.8M |
| 5 |
Roblox
RBLX
|
+$13.4M |
Sector Composition
| 1 | Technology | 21.58% |
| 2 | Energy | 13.05% |
| 3 | Healthcare | 8.58% |
| 4 | Financials | 8.4% |
| 5 | Communication Services | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
SPDR Gold MiniShares Trust
GLDM
$19.9B
| $163K | ﹤0.01% |
3,125
+210
| +7% | +$10.9K |
|
1027
Erasca
ERAS
$440M
| $162K | ﹤0.01% |
59,384
-45,097
| -43% | -$123K |
|
1028
Caribou Biosciences
CRBU
$166M
| $162K | ﹤0.01% |
82,494
+41,948
| +103% | +$82.2K |
|
|
EXAI
1029
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $162K | ﹤0.01% |
33,095
+415
| +1% | +$2.03K |
|
1030
Cognizant
CTSH
$33.8B
| $161K | ﹤0.01% |
+2,092
| New | +$161K |
|
1031
BioNTech
BNTX
$24.3B
| $161K | ﹤0.01% |
1,356
-984
| -42% | -$117K |
|
1032
iShares Core S&P Mid-Cap ETF
IJH
$100B
| $161K | ﹤0.01% |
+2,580
| New | +$161K |
|
1033
Adicet Bio
ACET
$66.9M
| $161K | ﹤0.01% |
111,642
+5,634
| +5% | +$8.11K |
|
1034
Mersana Therapeutics
MRSN
$36.7M
| $161K | ﹤0.01% |
3,400
+1,663
| +96% | +$78.6K |
|
1035
MacroGenics
MGNX
$109M
| $161K | ﹤0.01% |
48,823
+35,291
| +261% | +$116K |
|
1036
Iovance Biotherapeutics
IOVA
$861M
| $160K | ﹤0.01% |
17,071
+1,776
| +12% | +$16.7K |
|
1037
Pool Corp
POOL
$11.9B
| $160K | ﹤0.01% |
+425
| New | +$160K |
|
1038
Halozyme
HALO
$8.87B
| $160K | ﹤0.01% |
2,796
+1,337
| +92% | +$76.5K |
|
1039
EPAM Systems
EPAM
$8.53B
| $159K | ﹤0.01% |
801
+682
| +573% | +$136K |
|
1040
Xencor
XNCR
$596M
| $159K | ﹤0.01% |
7,918
-1,948
| -20% | -$39.2K |
|
1041
Legend Biotech
LEGN
$6.18B
| $159K | ﹤0.01% |
3,265
-23
| -0.7% | -$1.12K |
|
1042
Black Hills Corp
BKH
$4.28B
| $159K | ﹤0.01% |
2,598
-285
| -10% | -$17.4K |
|
1043
Precigen
PGEN
$1.22B
| $159K | ﹤0.01% |
167,496
+15,525
| +10% | +$14.7K |
|
1044
Immunocore
IMCR
$1.83B
| $158K | ﹤0.01% |
5,075
+1,461
| +40% | +$45.5K |
|
1045
Monte Rosa Therapeutics
GLUE
$296M
| $158K | ﹤0.01% |
29,798
-5,888
| -16% | -$31.2K |
|
1046
Royal Caribbean
RCL
$92.8B
| $157K | ﹤0.01% |
888
+628
| +242% | +$111K |
|
1047
Medtronic
MDT
$118B
| $157K | ﹤0.01% |
1,748
-110,756
| -98% | -$9.97M |
|
1048
PACCAR
PCAR
$51.8B
| $157K | ﹤0.01% |
1,592
-6,991
| -81% | -$690K |
|
1049
Kura Oncology
KURA
$709M
| $157K | ﹤0.01% |
8,024
-1,864
| -19% | -$36.4K |
|
1050
Sutro Biopharma
STRO
$77.2M
| $157K | ﹤0.01% |
45,260
-8,935
| -16% | -$30.9K |
|